Search research articles
Contact Us
Filters
Showing results (121-130 of 273) with videos related to
Page
of 28
Sort By:
Journal of Alzheimer'S Disease : JAD
|
June 6, 2018
Role of Amyloid-β and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade
Walter Gulisano, Daniele Maugeri, Marian A Baltrons, et al.
Archives of Neurology
|
August 12, 2009
Seizures in Alzheimer disease: who, when, and how common?
Nikolaos Scarmeas, Lawrence S Honig, Hyunmi Choi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 1999
Multicenter, phase II trial of exemestane as third-line hormonal therapy of postmenopausal women with metastatic breast cancer. Aromasin Study Group
S Jones, C Vogel, A Arkhipov, et al.
Journal of the International Neuropsychological Society : JINS
|
April 29, 2020
Leukocyte Telomere Length Is Unrelated to Cognitive Performance Among Non-Demented and Demented Persons: An Examination of Long Life Family Study Participants
Adiba Ashrafi, Stephanie Cosentino, Min S Kang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Basic Science and Pathogenesis
Hsin-Pei Wang, Naomi Saito, Laurel Beckett, et al.
Journal of Alzheimer'S Disease : JAD
|
March 1, 2021
Olfactory Impairment Is Related to Tau Pathology and Neuroinflammation in Alzheimer's Disease
Julia Klein, Xinyu Yan, Aubrey Johnson, et al.
Science Translational Medicine
|
November 26, 2020
Tau and other proteins found in Alzheimer's disease spinal fluid are linked to retromer-mediated endosomal traffic in mice and humans
Sabrina Simoes, Jessica L Neufeld, Gallen Triana-Baltzer, et al.
Theranostics
|
August 9, 2023
Focused ultrasound mitigates pathology and improves spatial memory in Alzheimer's mice and patients
Maria Eleni Karakatsani, Robin Ji, Maria F Murillo, et al.
Journal of Alzheimer'S Disease : JAD
|
June 23, 2020
Safety, Tolerability, and Pharmacokinetics of Crenezumab in Patients with Mild-to-Moderate Alzheimer's Disease Treated with Escalating Doses for up to 133 Weeks
Heather Guthrie, Lawrence S Honig, Helen Lin, et al.
Journal of Molecular Neuroscience : MN
|
December 24, 2011
Clinical and pathological characteristics of LRRK2 G2019S patients with PD
Markos Poulopoulos, Etty Cortes, Jean-Paul G Vonsattel, et al.
Page
of 28
Search research articles
Search
Showing results (121-130 of 273) with videos related to
Sort By:
Page
of 28
Journal of Alzheimer'S Disease : JAD
|
June 6, 2018
Role of Amyloid-β and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade
Walter Gulisano, Daniele Maugeri, Marian A Baltrons, et al.
Archives of Neurology
|
August 12, 2009
Seizures in Alzheimer disease: who, when, and how common?
Nikolaos Scarmeas, Lawrence S Honig, Hyunmi Choi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 1999
Multicenter, phase II trial of exemestane as third-line hormonal therapy of postmenopausal women with metastatic breast cancer. Aromasin Study Group
S Jones, C Vogel, A Arkhipov, et al.
Journal of the International Neuropsychological Society : JINS
|
April 29, 2020
Leukocyte Telomere Length Is Unrelated to Cognitive Performance Among Non-Demented and Demented Persons: An Examination of Long Life Family Study Participants
Adiba Ashrafi, Stephanie Cosentino, Min S Kang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Basic Science and Pathogenesis
Hsin-Pei Wang, Naomi Saito, Laurel Beckett, et al.
Journal of Alzheimer'S Disease : JAD
|
March 1, 2021
Olfactory Impairment Is Related to Tau Pathology and Neuroinflammation in Alzheimer's Disease
Julia Klein, Xinyu Yan, Aubrey Johnson, et al.
Science Translational Medicine
|
November 26, 2020
Tau and other proteins found in Alzheimer's disease spinal fluid are linked to retromer-mediated endosomal traffic in mice and humans
Sabrina Simoes, Jessica L Neufeld, Gallen Triana-Baltzer, et al.
Theranostics
|
August 9, 2023
Focused ultrasound mitigates pathology and improves spatial memory in Alzheimer's mice and patients
Maria Eleni Karakatsani, Robin Ji, Maria F Murillo, et al.
Journal of Alzheimer'S Disease : JAD
|
June 23, 2020
Safety, Tolerability, and Pharmacokinetics of Crenezumab in Patients with Mild-to-Moderate Alzheimer's Disease Treated with Escalating Doses for up to 133 Weeks
Heather Guthrie, Lawrence S Honig, Helen Lin, et al.
Journal of Molecular Neuroscience : MN
|
December 24, 2011
Clinical and pathological characteristics of LRRK2 G2019S patients with PD
Markos Poulopoulos, Etty Cortes, Jean-Paul G Vonsattel, et al.
Page
of 28